| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
 | 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
SCIGEN LIMITED (SIE)
Stock Code: SIE
Listing Date: 2002-11-15 00:00:00
Website: http://www.scigen.com.au
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Involved in the development, marketing and sales of a portfolio of bio-pharmaceutical products. These products include vaccines, which are designed to prevent disease and therapeutic bio-pharmaceuticals, which are intended to cure, suppress or minimize disease progression.
Address:
13B Narabang Way, Suite 1
Belrose
NSW 2085
Phone: 02-9485-1800
Fax: 02-9485-1888
Executives & Directors
Mr Saul Mashaal, Chairman, CEO
Ms Jenny Low Saw Imm, Vice President
Mr Kenneth Gross, Non Exec. Director
Mr Adam Wilezega, Non Exec. Director
Mr Ryszard Krauze, Non Exec. Director
Dr Marian Gorecki, Non Exec. Director
Mr Paul Freiman, Independent Director
Mr Martin Cooper, CFO
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
| Interim Results | Fri, 15 Aug 2008 | |
| Annual General Meeting | Thu, 26 Jun 2008 09:30AM |
|
| Full Year Results | Thu, 1 May 2008 | |
| Full Year Results | Fri, 29 Feb 2008 | |
| Interim Results | Tue, 14 Aug 2007 | |
| Annual General Meeting | Fri, 1 Jun 2007 09:30AM |
|
| Interim Results | Wed, 28 Feb 2007 | |
| Full Year Results | Wed, 28 Feb 2007 | |
| Annual General Meeting | Mon, 20 Nov 2006 09:30AM |
|
| Full Year Results | Mon, 11 Sep 2006 | |
| Interim Results | Mon, 27 Feb 2006 | |
| Annual General Meeting | Mon, 21 Nov 2005 09:30AM |
SCIGEN LIMITED (SIE)
| Appendix 4C - quarterly | Thu, 30 Oct 2008 |
| Half Yearly Report and Accounts | Fri, 15 Aug 2008 |
| Appendix 4C - quarterly | Wed, 30 Jul 2008 |
| Initial Director`s Interest Notice | Mon, 7 Jul 2008 |
| Initial Director`s Interest Notice | Tue, 1 Jul 2008 |
| Results of Meeting | Thu, 26 Jun 2008 |
| Letter to Shareholders | Thu, 26 Jun 2008 |
| Notice of Annual General Meeting/Proxy Form | Mon, 26 May 2008 |
| Annual General Meeting - Voting Instruction Form | Mon, 26 May 2008 |
| Proxy Form | Mon, 26 May 2008 |
| Secures Approval of SciLin in China | Wed, 21 May 2008 |
| Annual Report to shareholders | Thu, 1 May 2008 |
| Appendix 4C - quarterly | Wed, 30 Apr 2008 |
| Company Update | Wed, 2 Apr 2008 |
| Full Year Statutory Accounts | Mon, 31 Mar 2008 |
| Preliminary Final Report | Fri, 29 Feb 2008 |
| Appendix 4C - quarterly | Fri, 1 Feb 2008 |
| SciGen Enters Into Agreement With NasVax | Mon, 10 Dec 2007 |
| Appendix 4C - quarterly | Wed, 31 Oct 2007 |
| SciGen Announces Partnership with Sandoz | Tue, 11 Sep 2007 |
| Half Yearly Report and Accounts | Wed, 15 Aug 2007 |
| SciGen Severs Ties With Ferring International | Wed, 15 Aug 2007 |
| Appendix 4C - quarterly | Tue, 31 Jul 2007 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.